A Study of COVID 19 Convalescent Plasma in High Risk Patients With COVID 19 Infection

Purpose of Study The purpose of this study to evaluate, the effectiveness of convalescent plasma in combatting the symptoms and effects of the coronavirus disease, COVID-19. Beyond supportive care, there are no proven treatment options for COVID-19.

Observational Evaluation of Atopic Dermatitis in Pediatric Patients (PEDISTAD)

Prevalence of Severe Bleeding in COVID-19 Patients Treated With Higher Than Recommended Thromboprophylaxis Doses

ul>

Prevalence of DVT or PE in Patients Infected With COVID-19 Admitted to Hospital

Mucopolysaccharidosis I (MPS I) Registry

The data collected by the MPS I Registry will provide information to better characterize the natural history and progression of MPS I as well as the clinical responses of patients receiving enzyme replacement therapy, such as Aldurazyme (Recombinant Human Alpha-L-Iduronidase), or other treatment modalities.

The objectives of the Registry …

Pompe Disease Registry

ul>

Ventilator Strategies in ICU Patients With COVID-19 - a National-wide Retrospective Observational Study.

ul>

This study will provide important data on the ventilation strategies used and its potential adverse events in unselected ICU patients with COVID-19 and thereby inform clinicians, patients, policy-makers, and future research in this area.

Use of PCR-Sars-CoV-2 in Children

This algorithm, in two parts, can be used, when symptoms are detected in children, to orient and guide :

International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry

Gaucher Pregnancy Sub-registry: The primary objective of this Sub-registry is to track pregnancy outcomes, including complications and infant growth, in all women with Gaucher disease during pregnancy, regardless of whether they receive disease-specific therapy.

Fabry Disease Registry & Pregnancy Sub-registry

No experimental intervention is involved; patients in the Registry undergo clinical assessments and receive care as determined by the patient's treating physician.